As presented in Table 3, there were no significant differences in the improvement of serum Cr, Na, AST, ALT, albumin, HBV-DNA, or the ALBI score between the two cohorts of patients with HBV-LC. This evidence concerns the gene GPT and laryngotracheoesophageal cleft.